COMMUNIQUÉS West-GlobeNewswire

MyVii Foundation Releases new STD awareness campaign “Spread the AFFECTION not the INFECTION”
26/03/2018
TORONTO, March 26, 2018 (GLOBE NEWSWIRE) -- MyVii Foundation (Non-Profit) On February 13 th of this year, Maren Melnick discovered that several of her friends were recently diagnosed with an STD. That same day she [...]
Share buy-back week 12/2018
26/03/2018
Announcement 26 March 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]
Micron Solutions, Inc. Reports 2017 Fourth Quarter and Year End Results
26/03/2018
FITCHBURG, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Precision Therapeutics to Hold Business Update Conference Call on April 2, 2018
26/03/2018
MINNEAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT ) (“Precision” or “the Company”), formerly Skyline Medical, a company focused on applying artificial intelligence to personalized [...]
Onconova Presents Promising Data from Phase 2 Expansion Study of Oral Rigosertib and Azacitidine Combination in Patients with Myelodysplastic Syndromes at 6th International Bone Marrow Failure Disease Symposium
26/03/2018
First presentation from dose exploration cohorts in an expanded trial addressing urinary safety of the novel combination therapy in higher risk patients with Myelodysplastic Syndromes (MDS) Study demonstrates [...]
Novo Nordisk A/S: Share repurchase programme
26/03/2018
Bagsværd, Denmark, 26 March 2018 - On 5 February 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Organovo Division Samsara Sciences Announces Multi-Year Supply Agreement With Lonza Bioscience Solutions
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today announced that its wholly-owned subsidiary, Samsara Sciences, Inc. (“Samsara”), a provider of highly specialized [...]
Physeon GmbH to Present at MedTech Strategist Innovation Summit - Dublin, Ireland April 17-19, 2018
26/03/2018
SCHAFFHAUSEN, Switzerland, March 26, 2018 (GLOBE NEWSWIRE) -- Physeon® GmbH, (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, today announced that the Company will be a [...]
Drug Master File for Prostate Imaging Product Filed with the FDA
26/03/2018
MELBOURNE, Australia and INDIANAPOLIS, March 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix Group”, “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Tauriga Sciences, Inc. Elects to Change the Name of its Recently Formed Delaware Subsidiary to: Tauriga Biz Dev Corp.
26/03/2018
NEW YORK, NY, March 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
Catalyst Biosciences Receives $1.5 Million In Two Milestone Payments for Neuronal Nicotinic Receptor (NNR) Asset
26/03/2018
The TC-6499 asset sale may provide up to $35.5 million in remaining development, regulatory and commercial milestone payments plus net sales royalties and sub-license fees SOUTH SAN FRANCISCO, Calif., March 26, 2018 ( [...]
Trillium Dental Announces New Brand Identity
26/03/2018
OTTAWA, March 26, 2018 (GLOBE NEWSWIRE) -- Trillium Dental ®, recognized as Ottawa’s largest name in dentistry, has undergone a total brand review and today launches a new brand identity. The new brand offers a richer [...]
Aeglea BioTherapeutics Appoints Dr. Ivana Magovčević-Liebisch to Board of Directors
26/03/2018
AUSTIN, Texas, March 26, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE ), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with [...]
AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration for Bremelanotide for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in Premenopausal Women
26/03/2018
WALTHAM, Mass., March 26, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG ) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for [...]
Poseida to Present P-BCMA-101 Phase 1 Data at the American Association for Cancer Research (AACR) Annual Meeting 2018
26/03/2018
SAN DIEGO, March 26, 2018 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that [...]
HempAmericana’s Potential CBD Oil Leadership Featured in CannaInvestor Magazine
26/03/2018
NEW YORK, March 26, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC:HMPQ) (“HempAmericana” or the “Company”) is excited to announce that the Company is the feature story in a new special edition of [...]
Tower One Enters Into Agreement to Acquire US Based Tower Services Company With Over $17 Million in 2017 Revenue
26/03/2018
VANCOUVER, British Columbia, March 26, 2018 (GLOBE NEWSWIRE) -- Tower One Wireless Corp (CSE:TO) (OTCQB:TOWTF) (Frankfurt: 1P3N ) (“Tower One” or the “Company”) announces it has entered into an agreement to acquire a [...]
RedHill Biopharma Announces DDW 2018 Poster of Distinction on Positive Phase II Results with BEKINDA® for IBS-D
26/03/2018
TEL-AVIV, Israel and RALEIGH, N.C., March 26, 2018 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ: RDHL ) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily [...]
Premier Biomedical Inc., CEO William Hartman Visits Uptick Newswire’s “Stock Day” with Everett Jolly
26/03/2018
Phoenix, March 26, 2018 (GLOBE NEWSWIRE) -- Premier Biomedical Inc., (OTC: BIEI) ("the Company"), today reviewed recent accomplishments in interview on Uptick Newswire’s “Stock Day” podcast with Everett Jolly. Premier [...]

Pages